HIV and viral hepatitis coinfections: advances and challenges

scientific article published on May 2012

HIV and viral hepatitis coinfections: advances and challenges is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/GUTJNL-2012-302062
P698PubMed publication ID22504919

P2093author name stringKarine Lacombe
Juergen Rockstroh
P407language of work or nameEnglishQ1860
P921main subjectviral hepatitisQ1983841
P304page(s)i47-58
P577publication date2012-05-01
P1433published inGutQ5621669
P1476titleHIV and viral hepatitis coinfections: advances and challenges
P478volume61 Suppl 1

Reverse relations

cites work (P2860)
Q36732492A Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals
Q39037936An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.
Q28534869CCR5 haplotypes influence HCV serostatus in Caucasian intravenous drug users
Q30382346Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia
Q54243856Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options.
Q38675898Cross-Sectional Study to Determine the Prevalence of Hepatitis B and C Virus Infection in High Risk Groups in the Northeast Region of Brazil.
Q43065380Curative effect of hepatic portal venous administration of autologous bone marrow in AIDS patients with decompensated liver cirrhosis
Q28548313Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals
Q36783264Different faces of hepatocellular carcinoma as a health threat in 21st century
Q26786103Early-life exposures to infectious agents and later cancer development
Q52642614Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus-1: the EXPEDITION-2 Study.
Q40481513Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.
Q36698116Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study
Q90364811Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Q38204769Future considerations for dendritic cell immunotherapy against chronic viral infections
Q36015496HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary Care
Q34977282HIV and HCV coinfection: prevalence, associated factors and genotype characterization in the Midwest Region of Brazil
Q46317637HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar
Q35033499HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.
Q38918596Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa
Q36293979Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi
Q36083688Hepatitis C treatment initiation in HIV-HCV coinfected patients
Q42207980High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort
Q36268801High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany
Q37415420Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.
Q39503010Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011.
Q30364549Infection of female primary lower genital tract epithelial cells after natural pseudotyping of HIV-1: possible implications for sexual transmission of HIV-1.
Q40590338Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients
Q42669311Lack of a clinically significant drug-drug interaction in healthy volunteers between the hepatitis C virus protease inhibitor boceprevir and the HIV integrase inhibitor raltegravir
Q39491769Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana
Q35664183Management of chronic hepatitis B in patients from special populations
Q35042619Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Q44324472Morbidity and mortality in HIV infection
Q27006027New agents for the treatment of hepatitis C in patients co-infected with HIV
Q40899794New hepatitis C therapies for special patient populations
Q38295822Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals
Q40343820Performance of ANTI-HCV testing in dried blood spots and saliva according to HIV status
Q42223115Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications
Q41528360Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse
Q39613730Prevalence and Determinants of Cryptosporidium Infection in an Underdeveloped Rural Region of Southwestern China
Q40040535Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis
Q37272968Primary care of women aging with HIV.
Q41929282Profile of HIV subtypes in HIV/HBV- and HIV/HCV-coinfected patients in Southern Brazil
Q33594879Pros and cons of liver transplantation in human immunodeficiency virus infected recipients
Q91862651Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
Q36550395Sero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia
Q64101170Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana
Q37111444Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients
Q26740233Spotlight on grazoprevir-elbasvir once-daily combination and its potential in the treatment of hepatitis C
Q34981656Strategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated population
Q21559628The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban setting
Q54725550The γ-glutamyl transpeptidase-to-platelet ratio as a predictor of liver fibrosis in patients co-infected with HBV and HIV.
Q37620340Treatment of Hepatitis B: A Concise Review
Q38119893Update on HIV/HCV coinfection.
Q42233095Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.
Q39147842Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program
Q38203823Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations
Q36821936Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.

Search more.